Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Some people may temporarily lose more hair in certain areas after a hair transplant.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

COVID-19 may increase hair loss due to stress and inflammation.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

TNF-a may not be as involved in certain types of hair loss as previously thought.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.